Skip to content

The effect of leechtherapy on headache

The effect of leech therapy on primary headache in patients referring to Cupping unit

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014032717090N1
Enrollment
45
Registered
2014-06-07
Start date
2009-06-24
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary headache. Migraine, other headache syndromes

Interventions

Intervention 1: Leech therapy:1-3 leeches were placed behind the patient s ear. Each session lasted approximately 30-50 minutes. in average, each patient undertook leechtherapy, 1 to 3 session every 3
Treatment - Drugs
Leech therapy:1-3 leeches were placed behind the patient s ear. Each session lasted approximately 30-50 minutes. in average, each patient undertook leechtherapy, 1 to 3 session every 3 weeks.
Drug therapy (propranolol 40 mg, Nortriptyline 50 mg or citalopram 20 mg)daily

Sponsors

Vice Chancelor for research of Islamic Azad University of Shahroud
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criterion: diagnosis of primary headache by neurologist based on diagnostic parametres. Exclusion criteria: patients with brain tumors and other brain diseases; patients with sinusitis and anemia (Hb<10 g/dl); pregnant or breastfeeding women; patients with hemorrhagic disorders ; using anticoagulant drugs ; patients with acute medical conditions such as cardiac, renal and hepatic diseases.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of headache. Timepoint: Before and after intervention at first week , first month, second month and third month subsequently. Method of measurement: visual analogue scale.;Duration of headache. Timepoint: Before and after intervention at first week , first month, second month and third month subsequently. Method of measurement: time by hours in day.

Secondary

MeasureTime frame
Duration of disease. Timepoint: First visit. Method of measurement: interview.;Drug consumption. Timepoint: Before and after intervention at first week , first month, second month and third month subsequently. Method of measurement: self-reporting.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMr Mahmoud Bakhshi

Islamic Azad University of Shahroud

bakhshi_mahmoud@yahoo.com+98 27 3339 4342

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026